Formycon AG | Eyecare Industry News

Latest StoriesBusiness Legal Pipeline Research Events Products

Clinical ArticlesOcular SurfaceContact LensesGlaucomaRetinaPediatricsSEE MORE »

JobsOptometrist JobsOphthalmologist JobsOptician & Technician JobsHiring Services for EmployersSEE ALL JOBS »

Virtual EventsUpcoming Events

Stories

Business Legal Pipeline Research Events Products

FDA approves EYLEA biosimilar for serious retinal diseases

Formycon reports the generic biosimilar demonstrates a comparable efficacy, safety, pharmacokinetics, and immunogenicity to Regeneron’s aflibercept.

San Diego, CA+1 858-246-7066

Thank you to the Eyes On Eyecare Site Sponsor Astellas

Read our reviews on Google

Hiring ServicesSearch for JobsHiring Services for EmployersPost an Eyecare JobEyecare RecruitingPricingJob Sitemap

Learn MoreAbout UsContact UsNewsroomEditorial Policy

Clinical ArticlesOcular SurfaceContact LensGlaucomaRetinaNeuroLow Vision

Join The TeamCareersEditorial BoardBecome a Writer

Career ArticlesPersonal FinancePractice ManagementOptometry StudentsNew GraduateResidencySalary & Benefits

EventsEvent Schedule

Advertising, Media Kit, & Partnerships

Eyes On Eyecare is currently distributing our 2025 media kit and Eyes On event prospectuses. Contact us to learn more about available opportunities - spaces are limited.

Media Kit Event Prospectus

We're Hiring!

Do you work in the eyecare industry? Check out our open positions!

Open Positions

Eyes On Eyecare:

Optometry:

Ophthalmology:

Glance: